Page last updated: 2024-10-15

7-chloro-3-isopropylamino-4h-1,2,4-benzothiadiazine 1,1-dioxide

Description

7-chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide: activates ATP-sensitive potassium channels; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135410919
CHEMBL ID112668
SCHEMBL ID722204
MeSH IDM0374126

Synonyms (7)

Synonym
bpdz-73
bdbm50130735
(7-chloro-1,1-dioxo-1,4-dihydro-1lambda*6*-benzo[1,2,4]thiadiazin-3-yl)-isopropyl-amine
(7-chloro-1,1-dioxo-1,4-dihydro-benzo[1,2,4]thiadiazin-3-yl)-isopropyl-amine
CHEMBL112668 ,
SCHEMBL722204
7-chloro-3-isopropylamino-4h-1,2,4-benzothiadiazine 1,1-dioxide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-binding cassette sub-family C member 8 Rattus norvegicus (Norway rat)IC50 (µMol)0.48000.48000.48000.4800AID643188
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-binding cassette sub-family C member 8Homo sapiens (human)EC50 (µMol)0.25000.02191.12578.8000AID286541
ATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)EC50 (µMol)0.25000.02190.97088.8000AID286541
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (49)

Processvia Protein(s)Taxonomy
intracellular glucose homeostasisATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium ion transportATP-binding cassette sub-family C member 8Homo sapiens (human)
female pregnancyATP-binding cassette sub-family C member 8Homo sapiens (human)
memoryATP-binding cassette sub-family C member 8Homo sapiens (human)
visual learningATP-binding cassette sub-family C member 8Homo sapiens (human)
response to pHATP-binding cassette sub-family C member 8Homo sapiens (human)
response to xenobiotic stimulusATP-binding cassette sub-family C member 8Homo sapiens (human)
response to zinc ionATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of low-density lipoprotein particle clearanceATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of angiogenesisATP-binding cassette sub-family C member 8Homo sapiens (human)
response to lipopolysaccharideATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of tumor necrosis factor productionATP-binding cassette sub-family C member 8Homo sapiens (human)
response to insulinATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of potassium ion transportATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of insulin secretionATP-binding cassette sub-family C member 8Homo sapiens (human)
neuromuscular processATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of glial cell proliferationATP-binding cassette sub-family C member 8Homo sapiens (human)
glutamate secretion, neurotransmissionATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of neuroblast migrationATP-binding cassette sub-family C member 8Homo sapiens (human)
cellular response to organic substanceATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium ion transmembrane transportATP-binding cassette sub-family C member 8Homo sapiens (human)
inorganic cation transmembrane transportATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of uterine smooth muscle relaxationATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of tight junction disassemblyATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of blood-brain barrier permeabilityATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium ion import across plasma membraneATP-binding cassette sub-family C member 8Homo sapiens (human)
transmembrane transportATP-binding cassette sub-family C member 8Homo sapiens (human)
action potentialATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to hypoxiaATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to ischemiaATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ventricular cardiac muscle tissue developmentATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
glucose metabolic processATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
apoptotic processATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
determination of adult lifespanATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to xenobiotic stimulusATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to estradiolATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to ATPATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to testosteroneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
regulation of membrane potentialATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
negative regulation of insulin secretionATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
regulation of insulin secretionATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
nervous system processATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
CAMKK-AMPK signaling cascadeATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
cellular response to nicotineATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
cellular response to glucose stimulusATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
cellular response to tumor necrosis factorATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
potassium ion transmembrane transportATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
inorganic cation transmembrane transportATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
regulation of presynaptic membrane potentialATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
positive regulation of protein localization to plasma membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to resveratrolATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
potassium ion import across plasma membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
regulation of monoatomic ion transmembrane transportATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
ATP-activated inward rectifier potassium channel activityATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium channel activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATP bindingATP-binding cassette sub-family C member 8Homo sapiens (human)
sulfonylurea receptor activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATP-activated inward rectifier potassium channel activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATP hydrolysis activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATPase-coupled monoatomic cation transmembrane transporter activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ADP bindingATP-binding cassette sub-family C member 8Homo sapiens (human)
transmembrane transporter bindingATP-binding cassette sub-family C member 8Homo sapiens (human)
ABC-type transporter activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-binding cassette sub-family C member 8Homo sapiens (human)
voltage-gated potassium channel activityATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
protein bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ATP bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ATP-activated inward rectifier potassium channel activityATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ATPase-coupled monoatomic cation transmembrane transporter activityATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ankyrin bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
potassium ion bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
heat shock protein bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
transmembrane transporter bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (16)

Processvia Protein(s)Taxonomy
plasma membraneATP-binding cassette sub-family C member 8Homo sapiens (human)
inward rectifying potassium channelATP-binding cassette sub-family C member 8Homo sapiens (human)
synaptic vesicle membraneATP-binding cassette sub-family C member 8Homo sapiens (human)
sarcolemmaATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium ion-transporting ATPase complexATP-binding cassette sub-family C member 8Homo sapiens (human)
membraneATP-binding cassette sub-family C member 8Homo sapiens (human)
acrosomal vesicleATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
nuclear envelopeATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
endosomeATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
plasma membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
inward rectifying potassium channelATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
intercalated discATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
T-tubuleATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
axolemmaATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
presynaptic membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
neuronal cell bodyATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
cell body fiberATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
glutamatergic synapseATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
plasma membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (51)

Assay IDTitleYearJournalArticle
AID384243Inhibition of glucose-induced insulin secretion in Wistar rat pancreatic beta islets assessed as residual insulin secretion relative to control2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
AID249972Percent residual insulin release in rat pancreatic islets upon incubation with the compound (10 uM) at 37 degree C for 90 mins2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity.
AID195741Percent inhibition of residual insulin release from rat pancreatic islets in the presence of 16.7mM glucose at 0.1 uM concentration2003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID643191Drug metabolism in rat liver microsomes assessed as biotransformation into enantiomers of 7-chloro-3-(1-hydroxy-2-propyl)amino-4H-1,2,4-benzothiadiazine 1,1-dioxide by capillary electrophoresis2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stabil
AID246913Concentration giving 50% relaxation of the 30 mM KCl-induced contraction of rat aortic rings (n=6)2005Journal of medicinal chemistry, May-19, Volume: 48, Issue:10
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID195744Percent inhibition of residual insulin release from rat pancreatic islets in the presence of 16.7 mM glucose at 50 uM concentration2003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID444898Inhibition of glucose-induced insulin secretion in rat pancreatic islets assessed as residual insulin release at 1 uM2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.
AID444897Inhibition of glucose-induced insulin secretion in rat pancreatic islets assessed as residual insulin release at 10 uM2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.
AID286541Activity at Kir6.2/SUR1 KATP channels expressed in HEK293 cells assessed as repolarization of tolbutamide-induced membrane depolarization2007Journal of medicinal chemistry, May-03, Volume: 50, Issue:9
Virtual screening for novel openers of pancreatic K(ATP) channels.
AID596291Myorelaxant effect in Wistar rat uterus smooth muscle assessed as inhibition of contractions induced by bolus of oxytocin injected in superfusion system at 50 uM2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Impact of the nature of the substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides on their opening activity toward ATP-sensitive potassium channels.
AID195743Percent inhibition of residual insulin release from rat pancreatic islets in the presence of 16.7 mM glucose at 10 uM concentration2003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID251164Percent efficacy for inhibition of glucose stimulated insulin release from beta TC6 cells2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 K(ATP) channels.
AID444896Inhibition of glucose-induced insulin secretion in rat pancreatic islets assessed as residual insulin release at 50 uM2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.
AID444903Dissociation constant, pKa of the compound2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.
AID384241Inhibition of glucose-induced insulin secretion in Wistar rat pancreatic beta islets assessed as residual insulin secretion at 10 uM relative to control2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
AID195359Effective dose required for relaxation of the 30 mM KCl-induced contraction of rat aortic rings2003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID252258Ratio of EC50 required to relax KCl induced rat aorta ring contractions to that of IC50 required to inhibit insulin release in rat pancreatic islets2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity.
AID596288Inhibition of glucose induced insulin secretion from rat Pancreatic islet assessed as percentage of residual insulin release2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Impact of the nature of the substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides on their opening activity toward ATP-sensitive potassium channels.
AID444899Inhibition of glucose-induced insulin secretion in rat pancreatic islets assessed as residual insulin release at 0.1 uM2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.
AID384245Ratio of IC50 for glucose-induced insulin secretion in Wistar rat pancreatic beta islets to EC50 for myorelaxant activity in Wistar rat aorta rings2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
AID249971Percent residual insulin release in rat pancreatic islets upon incubation with the compound (1 uM) at 37 degree C for 90 mins2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity.
AID643190Selectivity index, ratio of EC50 for activation of KATP channel in rat aortic rings assessed as relaxation of KCl-induced contraction to IC50 for activation of SUR1 in rat pancreatic islets assessed as inhibition of glucose-induced insulin secretion2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stabil
AID195742Percent inhibition of residual insulin release from rat pancreatic islets in the presence of 16.7 mM glucose at 1 uM concentration2003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID248864Concentration required to inhibit insulin release in rat pancreatic islets by 50% upon incubation with the compound at 37 degree C for 90 mins2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity.
AID247947Concentration required for 50% inhibition of insulin release in rat pancreatic B-cells2005Journal of medicinal chemistry, May-19, Volume: 48, Issue:10
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID286542Activity at Kir6.2/SUR1 KATP channels expressed in HEK293 cells assessed as activation of K+ currents2007Journal of medicinal chemistry, May-03, Volume: 50, Issue:9
Virtual screening for novel openers of pancreatic K(ATP) channels.
AID384244Myorelaxant activity in potassium depolarized Wistar rat aorta rings assessed as relaxation of KCl-induced contraction2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
AID643188Activation of SUR1 in rat pancreatic islets assessed as inhibition of glucose-induced insulin secretion2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stabil
AID596290Myorelaxant effect in Wistar rat uterus smooth muscle assessed as inhibition of contractions induced by bolus of oxytocin injected in superfusion system at 100 uM2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Impact of the nature of the substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides on their opening activity toward ATP-sensitive potassium channels.
AID29349pKa value determined at pH 7.42003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID249397ED50/IC50 ratio was determined2005Journal of medicinal chemistry, May-19, Volume: 48, Issue:10
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID236597Ionization constant was determined2005Journal of medicinal chemistry, May-19, Volume: 48, Issue:10
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID248152Potency by glucose stimulated insulin release from HEK 293 cells2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 K(ATP) channels.
AID253201Effect on insulin secretion from rat pancreatic islets at 10 uM concentration (n=32)2005Journal of medicinal chemistry, May-19, Volume: 48, Issue:10
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID248136Concentration required for inhibition of glucose stimulated insulin release from beta TC6 cells2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 K(ATP) channels.
AID253213Effect on insulin secretion from rat pancreatic islets at 50 uM concentration (n=35)2005Journal of medicinal chemistry, May-19, Volume: 48, Issue:10
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID728946Activation of ATP-sensitive potassium channel opening in albino rat pancreatic islets assessed as inhibition of glucose-induced insulin release measured as residual insulin release at 10 uM after 90 mins by radioimmunoassay2013Journal of medicinal chemistry, Apr-25, Volume: 56, Issue:8
1,4,2-Benzo/pyridodithiazine 1,1-dioxides structurally related to the ATP-sensitive potassium channel openers 1,2,4-Benzo/pyridothiadiazine 1,1-dioxides exert a myorelaxant activity linked to a distinct mechanism of action.
AID246525Concentration required to relax KCl induced rat aorta ring contractions by 50% upon incubation with the compound at 37 degree C for 90 mins2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity.
AID233236Estimated selectivity ratio of ED50 and IC50 in rat was calculated2003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID643193Hydrosolubility of the compound by HPLC analysis2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stabil
AID248509inhibitory concentration required for repolarization of beta cell membrane potential in presence of 10 mM glucose2004Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 K(ATP) channels.
AID253190Effect on insulin secretion from rat pancreatic islets at 1 uM concentration (n=31)2005Journal of medicinal chemistry, May-19, Volume: 48, Issue:10
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID596292Myorelaxant effect in Wistar rat uterus smooth muscle assessed as inhibition of contractions induced by bolus of oxytocin injected in superfusion system at 10 uM2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Impact of the nature of the substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides on their opening activity toward ATP-sensitive potassium channels.
AID286545Activity at Kir6.2/SUR1 KATP channels expressed in HEK293 cells assessed as repolarization of tolbutamide-induced membrane depolarization relative to BPDZ732007Journal of medicinal chemistry, May-03, Volume: 50, Issue:9
Virtual screening for novel openers of pancreatic K(ATP) channels.
AID179405Concentration required to inhibit insulin release in rat2003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
AID728947Activation of ATP-sensitive potassium channel opening in albino rat aorta rings assessed as relaxation of KCl-induced contraction of aorta rings2013Journal of medicinal chemistry, Apr-25, Volume: 56, Issue:8
1,4,2-Benzo/pyridodithiazine 1,1-dioxides structurally related to the ATP-sensitive potassium channel openers 1,2,4-Benzo/pyridothiadiazine 1,1-dioxides exert a myorelaxant activity linked to a distinct mechanism of action.
AID249975Percent residual insulin release in rat pancreatic islets upon incubation with the compound (0.1 uM) at 37 degree C for 90 mins2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity.
AID286544Inhibition of insulin release from rat INS-1E cells2007Journal of medicinal chemistry, May-03, Volume: 50, Issue:9
Virtual screening for novel openers of pancreatic K(ATP) channels.
AID444900Myorelaxant activity in rat aortic ring assessed as inhibition of KCL-induced contraction2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.
AID384242Inhibition of glucose-induced insulin secretion in Wistar rat pancreatic beta islets assessed as residual insulin secretion at 1 uM relative to control2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
AID596282Dissociation constant, pKa of the compound2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Impact of the nature of the substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides on their opening activity toward ATP-sensitive potassium channels.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (61.54)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]